The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Sprouty1 regulates neuritogenesis and survival of cortical neurons
Abstract
In multicellular organisms, receptor tyrosine kinases (RTKs) control a variety of cellular processes, including cell proliferation, differentiation, migration, and survival. Sprouty (SPRY) proteins represent an important class of ligand‐inducible inhibitors of RTK‐dependent signaling pathways. Here, we investigated the role of SPRY1 in cells of the central nervous system (CNS). Expression of SPRY1 was substantially higher in neural stem cells than in cortical neurons and was increased during neuronal differentiation of cortical neurons. We found that SPRY1 was a direct target gene of the CNS‐specific microRNA, miR‐124 and miR‐132 . In primary cultures of cortical neurons, the neurotrophic factors brain‐derived neurotrophic factor (BDNF) and Basic fibroblast growth factor (FGF2) downregulated SPRY1 expression to positively regulate their own functions. In immature cortical neurons and mouse N 2 A cells, we found that overexpression of SPRY1 inhibited neurite development, whereas knockdown of SPRY1 expression promoted neurite development. In mature neurons, overexpression of SPRY1 inhibited the prosurvival effects of both BDNF and FGF2 on glutamate‐mediated neuronal cell death. SPRY1 was also upregulated upon glutamate treatment in mature neurons and partially contributed to the cytotoxic effect of glutamate. Together, our results indicate that SPRY1 contributes to the regulation of CNS functions by influencing both neuronal differentiation under normal physiological processes and neuronal survival under pathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Five of the miR-132 targets (BMI1, FOXO1, SPRY1, DPYSL3, CITED2) displaying the highest betweenness centrality, a proxy of network connectivity, have all shown to be involved in cell cycle, and more specifically, in neurogenesis [68–72] (Fig. 5D) (Supplementary Table 7).”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Additionally, multiple of these core miR-132 targets (e.g. FOXO1, DPYSL3, SPRY1, BMI1, and CITED2 via P300) have previously been identified as miR-132 targets in other cell types, supporting the notion that they represent true miR-132 targets [2, 72–79].”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [72]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Our data indicate that while there are common ‘core’ miR-132 targets across conditions, possibly involved in ‘housekeeping’ cellular functions, like cell cycle [68–72], there are also context-dependent targets, specific to healthy control or sAD iMGs.”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [72]
Experimental — accuracy not yet measuredIn the citing paper
“Five of the miR-132 targets (BMI1, FOXO1, SPRY1, DPYSL3, CITED2) displaying the highest betweenness centrality, a proxy of network connectivity, have all shown to be involved in cell cycle, and more specifically, in neurogenesis [68–72] (Fig. 5D) (Supplementary Table 7).”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0116-07.2007 · Cited by 773
DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Tu, W., Xu, X., Peng, L., Zhong, X., Zhang, W., Soundarapandian, M. M., Belal, C., Wang, M., Jia, N., Zhang, W., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.055 · Cited by 493
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA
Klein, M. E., Lioy, D. T., Ma, L., Impey, S., Mandel, G., & Goodman, R. H. (2007) · Nature Neuroscience · doi:10.1038/nn2010 · Cited by 444
miR-132 Mediates the Integration of Newborn Neurons into the Adult Dentate Gyrus
Luikart, B. W., Bensen, A. L., Washburn, E. K., Perederiy, J. V., Su, K. G., Li, Y., Kernie, S. G., Parada, L. F., & Westbrook, G. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019077 · Cited by 160
Flagged first, then by citations
Research works printed but not linked: 63
- 10.1371/journal.pone.0032087 · DOI
- 10.1007/s00018-003-3319-x · DOI · Paper page
- 10.1016/S0092-8674(04)00045-5 · DOI
- 10.1523/JNEUROSCI.23-12-04958.2003 · DOI
- 10.1016/S1672-0229(08)60044-3 · DOI
- 10.1038/mp.2017.61 · DOI · Paper page
- 10.1016/0896-6273(91)90347-3 · DOI
- 10.1038/nn.2294 · DOI · Paper page
- 10.1523/JNEUROSCI.07-02-00357.1987 · DOI
- 10.1016/S0166-2236(99)01463-0 · DOI
- 10.1016/S0925-4773(98)00241-X · DOI
- 10.1124/mol.109.055848 · DOI
- 10.1074/jbc.M706567200 · DOI
- 10.1523/JNEUROSCI.0307-10.2010 · DOI
- 10.1007/s00213-017-4823-2 · DOI
- 10.1126/science.7907431 · DOI · Paper page
- 10.1038/sj.cdd.4402188 · DOI
- 10.1074/jbc.M108234200 · DOI
- 10.1007/s12031-013-0190-6 · DOI
- 10.1016/S0092-8674(00)80919-8 · DOI
- 10.1016/S0960-9822(03)00086-1 · DOI
- 10.1038/ncb867 · DOI · Paper page
- 10.1523/JNEUROSCI.3371-13.2014 · DOI · Paper page
- 10.1038/nn835 · DOI · Paper page
- 10.1016/S0959-4388(96)80010-9 · DOI
- 10.1007/s13105-010-0050-6 · DOI
- 10.1016/j.jmb.2014.07.032 · DOI
- 10.1083/jcb.152.5.1087 · DOI
- 10.1101/gad.1097103 · DOI
- 10.1089/scd.2011.0110 · DOI
- 10.1016/j.neuroscience.2014.04.039 · DOI · Paper page
- 10.1038/ng1536 · DOI · Paper page
- 10.4049/jimmunol.0803799 · DOI
- 10.1016/j.cell.2004.12.035 · DOI · Paper page
- 10.1523/JNEUROSCI.0203-11.2011 · DOI
- 10.1242/jcs.01519 · DOI
- 10.1186/1471-2105-11-476 · DOI
- 10.1073/pnas.1015691107 · DOI · Paper page
- 10.1016/j.molcel.2007.07.015 · DOI · Paper page
- 10.1016/S0165-3806(96)00149-6 · DOI
- 10.1186/1757-2215-7-61 · DOI
- 10.1242/dev.126.20.4465 · DOI
- 10.1007/s000180050199 · DOI
- 10.1016/j.ydbio.2017.10.017 · DOI
- 10.1002/cyto.a.22161 · DOI
- 10.1006/bbrc.2001.5295 · DOI
- 10.1006/mcne.1999.0753 · DOI
- 10.1038/s41467‐017‐02322‐5 · DOI
- 10.1016/j.bcp.2011.12.025 · DOI
- 10.1038/35002090 · DOI
- 10.15252/emmm.201606520 · DOI · Paper page
- 10.4161/cc.2.4.418 · DOI
- 10.1074/jbc.C100386200 · DOI
- 10.1101/cshperspect.a008912 · DOI
- 10.1038/nrm2347 · DOI
- 10.1111/cns.12142 · DOI
- 10.1152/ajplung.00372.2001 · DOI
- 10.1152/jn.00771.2005 · DOI
- 10.1111/j.1471-4159.1989.tb07430.x · DOI
- 10.1016/S0166-2236(99)01500-3 · DOI
- 10.1016/j.yexcr.2008.06.002 · DOI
- 10.1074/jbc.M108368200 · DOI
- 10.1016/S0925-4773(01)00526-3 · DOI
Cited by
Sorted by citations
MicroRNA‑124: an emerging therapeutic target in central nervous system disorders
Zhang, W.-H., Jiang, L., Li, M., & Liu, J. (2023) · Experimental Brain Research · doi:10.1007/s00221-022-06524-2 · Cited by 43
Penning, A., Snoeck, S., Ormaechea, O. R., Ayyildiz, D., Polzer, O., Buitrago-Arango, M., Capobianco, R., de Winter, F., Balusu, S., Verhaagen, J., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02228-8 · Cited by 6
Metadata
- Authors
- Gu, X., Su, X., Jia, C., Lin, L., Liu, S., Zhang, P., Wang, X., & Jiang, X.
- Affiliations
- Department of Neurosurgery Zhujiang Hospital, Southern Medical University, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration Guangzhou China
- Department of Neurobiology Southern Medical University Guangzhou China
- Department of Cell Biology School of Basic Medical Science, Southern Medical University Guangzhou China
- ORCID
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-12-19
- Volume
- 234
- Issue
- 8
- Pages
- 12847-12864
- ISSN
- 0021-9541
- 1097-4652
- Cited by
- 10
- References
- 4
- Language
- en
- Licence
- Funders
- China Postdoctoral Science Foundation (2017M612695)
- National Natural Science Foundation of China (81874077, 81171179)
- Natural Science Foundation of Guangdong Province (2018A030313008)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review